Drug intelligence / Profile preview

iodine-125 seeds strand

Development stage
Unknown
Lead developer
Eckert & Ziegler
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Interstitial, Intratumoral, Intraluminal, Implantation
01

Overview

Iodine-125 seeds strand is a radiopharmaceutical device used for brachytherapy, where multiple radioactive iodine-125 (I-125) seeds are arranged in a linear configuration (strand) and implanted directly into or near tumor tissue. The I-125 isotope emits low-energy gamma radiation with a half-life of approximately 59.6 days, providing localized irradiation to destroy cancer cells while minimizing exposure to surrounding healthy tissue. The strands are typically encased in biocompatible materials such as titanium and can be delivered via catheters or needles under imaging guidance. This therapy is primarily indicated for localized prostate cancer but is also used for other malignancies including ureteral carcinoma and certain types of breast cancer. The mechanism of action involves continuous local emission of ionizing radiation that induces DNA damage in tumor cells, leading to cell death[2][3][4]. Manufacturers include companies such as Saide Biological Technology and Eckert & Ziegler Medical.

Brand names
OncoSeedEchoSeedI-SeedBrachySourceThinStrandProspera
Other names
I-125 seed strandI125 seed strandI 125 seed strandstranded iodine-125 brachytherapy source125I seed strand
02

Targets

DNA

Beyond the preview

Go deeper on iodine-125 seeds strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iodine-125 seeds strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call